Document:

<PAGE>

                                                                   EXHIBIT 10.8

                            PATENT LICENSE AGREEMENT

         This PATENT LICENSE AGREEMENT (this "Agreement"), dated December 5,
2003, (the "Effective Date") is made and entered into by and between N.V.
Nutricia, a company organized under the laws of The Netherlands (hereinafter the
"Licensor"), and General Nutrition Investment Company, an Arizona corporation
(hereinafter the "Licensee").

         WHEREAS, Licensor is the owner of technology covered by certain Patent
Rights (hereinafter defined) related to certain compositions that may be
suitable for sale by Licensee.

         WHEREAS, Licensee desires to acquire a non-exclusive right and license
from Licensor for restricted exploitation of the Patent Rights within the
Protected Business (as defined in that certain Purchase Agreement, dated as of
October 16, 2003, among Royal Numico N.V., Numico USA, Inc. and Apollo GNC
Holding, Inc., as amended (the "Purchase Agreement")) in order to develop,
manufacture, have manufactured, market, offer for sale and sell certain product
compositions.

         WHEREAS, Licensor desires to grant such right and license to Licensee.

         WHEREAS, this Agreement is made pursuant to and is subject to the terms
and conditions of the Purchase Agreement.

         NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereto, intending to be
legally bound, hereby agree as follows:

1.       DEFINITIONS

         1.1      As used in this Agreement, the capitalized terms set forth
herein shall have the following meanings:

                  (a)      "LICENSED PRODUCTS" means a product composition that
         is sold only within the Protected Business, which if made, used or sold
         by Licensee, in the absence of the rights and license granted under
         this Agreement, would infringe one or more claims of the Patent Rights.

                  (b)      "PATENT RIGHTS" means (i) the patent applications
         (the "Patent Applications") set forth in Exhibit A, attached hereto and
         incorporated herein, and (ii) any counterpart patents or patent
         applications that are equivalents of the Patent Applications issued,
         granted or filed in any country other than the original filing country
         (the "Counterpart Patents"), exclusive of any continuation,
         continuation-in-part, divisional, reexamination, reissue or any other
         patent right of the Patent Applications not expressly set forth herein.

<PAGE>

                  (c)      "TERM" means the term of this Agreement as further
         defined in Article 7 below.

         1.2      Capitalized terms used but not defined herein shall have the
meanings assigned thereto in the Purchase Agreement.

2.       LICENSE GRANT

         2.1      Licensor hereby grants to Licensee, subject to the terms and
conditions of this Agreement, a personal, non-exclusive, royalty-free right and
license, without the right to sublicense, except as expressly provided in
Section 2.2, under the Patent Rights to make, have made, use, offer for sale and
sell Licensed Products solely within the Protected Business.

         2.2      The right and license granted to Licensee is personal to
Licensee. Licensee shall not at any time: (a) sublicense such rights, or assign
or transfer such right and license granted herein to any Person, except an
Affiliate of Licensee, without the prior written consent of Licensor; nor (b)
permit any Lien upon such right and license. Notwithstanding the foregoing, this
Agreement shall be assignable as of right with any transfer of substantially all
of the assets and the entire business associated therewith by the Licensee or
its Affiliate, provided that: (i) Licensee is in full compliance with all of the
terms and conditions of this Agreement; (ii) the acquiror of such assets and
business agrees in writing to assume all obligations of Licensee or its
Affiliate under this Agreement pursuant to an instrument in form and substance
reasonably satisfactory to Licensor; and (iii) Licensee or its Affiliate gives
Licensor prior written notice of such transfer and the identity of such
acquirer. Any attempted assignment or other transfer in contravention of this
Section 2.2 shall be void and ineffective.

         2.3      Licensee shall restrict its practice of the Patent Rights to
Licensed Products within the Protected Business only, and covenants not to
practice the Patent Rights for any purpose outside the Protected Business.

         2.4      Notwithstanding anything to the contrary in this Agreement,
Licensee agrees to accept the right and license granted in this Article 2
subject to any outstanding licenses or other rights of third parties under
agreements executed by Licensor prior or subsequent to the date of this
Agreement.

3.       MARKING

         3.1      Licensee agrees to lawfully mark all Licensed Products (or
their containers or labels) with a proper patent marking based on the Patent
Rights pursuant to the U.S. Code Title 35 or any other international marking
requirements.

                                       2

<PAGE>

4.       PROSECUTION AND MAINTENANCE

         4.1      Licensor may, as it determines in its sole discretion: (a)
prosecute any and all U.S. and foreign patent applications included in or
related to the Patent Rights (the "Prosecution"); and (b) pay maintenance or
annuity fees of any and all U.S. and foreign patents which result from the
Patent Rights (the "Maintenance"). Upon Licensee's written request, Licensor
will furnish copies of specifically requested Patent Rights-related documents to
Licensee.

         4.2      In the event Licensor decides not to pursue Prosecution or
Maintenance of any of the Patent Rights, Licensor shall provide reasonable
notice to Licensee thereof. If Licensee desires, at its sole cost, expense and
discretion, to assume and continue the obligations of Prosecution or Maintenance
of such Patent Rights, upon request by Licensee, Licensor shall execute and
deliver such documents and perform such acts as may be reasonably necessary to
effect assignment of all right, title and interest in and to such Patent Rights
to Licensee, subject to any outstanding rights or licenses granted prior to such
assignment, without further consideration from Licensee.

         4.3      In the event that letters patent are issued or granted based
on any patent application so assigned in accordance with Section 4.2, Licensee
shall restrict its practice of such letters patent to making, having made,
using, offering for sale and selling products covered by the claims of such
letters patent within the Protected Business and hereby grants to Licensor an
exclusive, royalty-free right and license, with the right to sublicense, under
such letters patent to make, have made, use, offer for sale and sell any
products covered by the claims of such letters patent outside the Protected
Business and, except where the context otherwise requires, on such other terms
as the Patent Rights provided in this Agreement as if such Patent Rights
included such letters patent, Licensor as the Licensee hereunder with respect to
such letters patent and Licensee as the Licensor hereunder with respect to such
letters patent.

5.       INFRINGEMENT BY THIRD PARTIES

         5.1      Each party shall promptly give notice to the other of any
actual or potential infringement of any Patent Right by any third party that
becomes known to such first-mentioned party. Licensor shall have the first right
to take such action it determines, in its sole discretion, to be necessary to
terminate or prevent any actual or potential infringement of such Patent Right.
If Licensor has not taken any action (including an informed decision to take no
action) within one hundred twenty (120) days from such first-mentioned party's
notice, Licensee may submit to Licensor a notice that Licensee will take such
action as Licensee reasonably determines is necessary to terminate or prevent
the infringement, including filing suit to the extent provided by any applicable
law, rule or regulation, unless Licensor notifies Licensee that Licensor will
file suit

                                       3

<PAGE>

or otherwise terminate such infringement within thirty (30) days after
Licensor's receipt of such notice from Licensee.

         5.2      In the event Licensor files suit to stop infringement,
Licensor may enter into any settlement, consent judgment or other voluntary
final disposition of such suit at its sole discretion. In the event Licensee
elects to join Licensor in any such suit or action, Licensee shall pay it's own
attorneys' fees and costs of its participation in such suit or action.
Regardless if Licensee joins or does not join Licensor in any such suit or
action, upon request by Licensor, Licensee shall cooperate with Licensor in such
suit or action. In the event Licensor requests Licensee to join Licensor in
participation in such suit or action, Licensee shall have the right to consult
with Licensor and be represented by counsel at Licensor's sole expense. Any
recovery of damages from any suit or action brought by Licensor, where Licensee
has joined Licensor, shall be shared equally by the parties, after recovery by
Licensor of its costs and expenses in connection therewith, including attorney's
fees.

         5.3      In the event Licensee solely files suit to stop infringement,
Licensee may enter into any settlement, consent judgment or other voluntary
final disposition of such suit subject to Licensor's approval. Any recovery of
damages from any suit or action brought solely by Licensee shall be retained by
Licensee.

6.       COSTS; EXPENSES AND TAXES

         6.1      Except as otherwise provided herein, each party shall bear its
own costs and expenses incurred by it in performing its obligations hereunder.

         6.2      Each party shall be responsible for payment of any applicable
sales, use and income taxes, including any privilege or excise taxes in the
nature of sales or use taxes, and other similar charges imposed upon it by any
jurisdiction arising from the performance of its obligations under this
Agreement.

7.       TERM AND TERMINATION

         7.1      The Term of this Agreement shall run from the Effective Date
of this Agreement and shall terminate automatically upon the expiration or
extinguishment of all of the Patent Rights set forth in Exhibit A and all
letters patent that may be issued as contemplated by Section 4.3, subject to
early termination, as set forth herein below:

                  (a)      Either party shall have the right to terminate this
         Agreement without judicial resolution upon written notice to the other
         party of a material breach of any provision of this Agreement by such
         other party that is not cured within sixty (60) days after such notice.

                                        4

<PAGE>

                  (b)      This Agreement shall be terminated immediately upon
         Licensor and Licensee reaching mutual agreement to so terminate this
         Agreement.

                  (c)      Licensee may terminate this Agreement without cause
         upon sixty (60) days notice to Licensor.

                  (d)      This Agreement shall automatically terminate, without
         requirement of notice, upon the occurrence of any of the following:

                           (i)      any attempt by Licensee to assign or
                  otherwise transfer its interest in whole or in part, in this
                  Agreement voluntarily or by operation of law to any other
                  third party except as otherwise permitted herein; or

                           (ii)     a cessation by Licensee of all or
                  substantially all of its business, or

                           (iii)    a petition in bankruptcy or reorganization
                  is filed by Licensee under any applicable bankruptcy law now
                  or hereafter in force or shall be filed against Licensee and
                  not vacated or dismissed within sixty (60) days after such
                  filing; or Licensee shall make an assignment for the benefit
                  of its creditors, or a receiver, trustee, liquidator or
                  custodian shall be appointed for all or a substantial part of
                  Licensee's property, and the order of appointment is not
                  vacated or dismissed within sixty (60) days after it is made;
                  or all or any material portion of Licensee's property shall be
                  sequestered, and the order of sequestration is not vacated or
                  dismissed within sixty (60) days after it is entered; or
                  Licensee shall generally fail or admit in writing its
                  inability to pay its debts as such debts become due and
                  payable.

         7.2      The following provisions of this Agreement shall survive
termination: Sections 7.3, 7.4 and 7.5, and Articles 6, 8, 9 and 10.

         7.3      Neither party shall be relieved of any obligation or liability
under this Agreement arising from any act or omission committed prior to the
effective date of such termination.

         7.4      Upon termination of this Agreement for any reason, and for one
(1) year following the effective date of termination, Licensee may continue to
sell any inventory of Licensed Products in its possession or control which was
manufactured, for which Licensee had issued binding commitments to manufacture
or for which Licensee had purchased or ordered raw materials to manufacture (all
in the ordinary course of business) prior to the effective date of termination.

                                       5

<PAGE>

         7.5      Except as specified in Section 7.4, from and after any
termination of this Agreement, Licensee shall not make or have made, use or have
used or sell or have sold any Licensed Products under any of the Patent Rights.

         7.6      The rights and remedies granted herein, and any other rights
or remedies which the parties may have, either at law or in equity, are
cumulative and not exclusive of others.

8.       LIMITATIONS OF WARRANTIES

         8.1      PATENT RIGHTS ARE PROVIDED "AS IS" WITH NO WARRANTIES OR
REPRESENTATIONS OF ANY KIND, AND LICENSOR EXPRESSLY DISCLAIMS ALL OTHER
WARRANTIES OR REPRESENTATIONS, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED
TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, TITLE, NON-INFRINGEMENT OR
FITNESS FOR A PARTICULAR PURPOSE.

9.       INDEMNIFICATION

         9.1      Licensee shall indemnify, defend and hold harmless Licensor
and its Affiliates against all damages, costs, and expenses, including
reasonable attorney's fees, arising or resulting from, but not limited to,
Licensee making, having made, using, offering for sale or selling the Licensed
Products based upon the Patent Rights in whatever form, provided that Licensor
promptly notifies Licensee in writing of any claim or action, Licensee has sole
control of the defense and all related settlement negotiations, Licensor will
reasonably cooperate, at Licensee's expense, in the defense of such claim or
action and Licensor may fully participate to protect its own interests, at
Licensee's expense, if Licensor determines that such participation is necessary.

10.      LIMITATION OF LIABILITY

         10.1     Neither Licensor nor its Affiliates will be responsible for
any injury to or death of persons, or damage to or destruction of materials, or
other property, or for any other loss, damage, or injury of any kind whatsoever
resulting from Licensee making, having made, using, offering for sale or selling
of the Licensed Products based upon the Patent Rights.

11.      GENERAL PROVISIONS

         11.1     Under the terms of this Agreement, Licensor and Licensee are
independent contractors. Neither party is an employee, agent, partner or
representative of the other party. Nothing contained herein shall be deemed to
create a joint venture relationship between the parties. Each party specifically
acknowledges that it does not have authority to incur any obligations or
responsibilities on behalf of the other party.

                                        6

<PAGE>

         11.2     All notices required or permitted to be given by one party to
the other under this Agreement shall be sufficient if sent by certified mail,
return receipt requested, by a nationally recognized courier or by hand delivery
to the parties at the respective addresses set forth below or to such other
address as the party to receive the notice has designated by notice to the other
party:

Licensor:                                Licensee:
N.V. Nutricia                            General Nutrition Investment Company
Bosrandweg 20                            300 Sixth Street
6704 PH Wageningen                       Pittsburgh, Pennsylvania 15222
Netherlands                              Fax No.________________________
Fax No.________________                  Attn: _________________________
Attn: _________________

         All notices shall be effective upon receipt or refusal of delivery by
the party being notified. Either party may change its address, etc., by giving
notice of such change as provided herein, provided that such notice is effective
only on receipt.

         11.3     Licensee shall not use the name of the Licensor or any of its
Affiliates in any advertising, marketing or sales without the prior written
consent of Licensor, except that Licensee may state that the Licensed Products
are licensed under the Patent Rights, Licensee may mark the Licensed Products
pursuant to Section 3 of this Agreement and Licensee may use Licensor's name in
various documents used by Licensee for capital raising and financing without
such prior written consent only to the extent such use is required by any U.S.
federal law or regulation. However, by entering into this Agreement, Licensor
does not directly or indirectly endorse any Licensed Products and Licensee shall
not state or imply that this Agreement is an endorsement by Licensor.

         11.4     No waiver of the terms and conditions of this Agreement, or
the failure of either party to strictly enforce any such term or condition on
one or more occasions, shall be construed as a waiver of the same or of any
other term or condition of this Agreement on any other occasion.

         11.5     This Agreement shall be governed by and construed in
accordance with the internal laws of the State of New York, without reference to
any principles of conflicts of laws. The parties hereby consent to the
jurisdiction and venue of the United States district courts sitting in the State
of New York and any courts of the State of New York in which any suit, action or
proceeding is brought arising under this Agreement. The parties hereby waive any
claim of forum non conveniens in any suit, action or proceeding brought in any
of the above-mentioned courts. Licensor and Licensee agree that service of
process in any such suit, action or proceeding shall be effective if in writing,
delivered in

                                        7

<PAGE>

any manner permitted in Section 11.2 hereof and actually received by the
addressee.

         11.6     If any provision in this Agreement may be held to be invalid
or unenforceable in any jurisdiction in which this Agreement is being performed,
the meaning of such provision shall be construed so as to render it enforceable
to the extent feasible. If no feasible interpretation would save such provision,
it shall be severed from this Agreement and the remainder shall remain in full
force and effect. However, in the event such provision is considered an
essential element of this Agreement, the parties shall promptly negotiate
alternative, reasonably equivalent, enforceable terms.

         11.7     Licensee shall comply with all laws, rules and regulations
applicable to the performance of its obligations hereunder, including, without
limitation, all import/export laws, restrictions, controls and regulations
relating to the Patent Rights and/or Licensed Products.

         11.8     Subject to the Purchase Agreement, the terms and conditions
contained in this Agreement, including the attached Exhibit A, supersede all
prior oral or written understandings between the parties with respect to the
subject matter thereof, and constitutes the entire agreement of the parties with
respect to such subject matter. All prior negotiations, representations,
agreements, and understandings are merged into, extinguished by and completely
expressed by this Agreement. Such terms and conditions shall not be modified or
amended except by a writing signed by authorized representatives of both
parties.

         11.9     This Agreement may be executed in several counterparts, each
of which shall be deemed an original, but all of which together shall constitute
one and the same Agreement. A signature page of this Agreement executed and
transmitted via facsimile or electronic mail shall be deemed an original for all
purposes.

         11.10    This Agreement shall be binding upon and shall inure to the
benefit of the parties hereto and their respective permitted assigns and
successors.

                            [SIGNATURE PAGE FOLLOWS]

                                        8

<PAGE>

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed below
by their duly authorized representatives.

N.V. Nutricia                                General Nutrition Corporation

By: /s/ Bert Moulet                          BY: /s/ James Sander
    ---------------------------                  -----------------------------

Printed Name: Bert Moulet                    Printed Name: James Sander

Title: EVP                                   Title: VP

                                       9

<PAGE>

                                    EXHIBIT A

<TABLE>
<CAPTION>
                                       APPLICATION                    PUBLICATION    ISSUE
               TITLE                      NUMBER         DATE FILED     NUMBER        DATE      COUNTRY
---------------------------------    ----------------    ----------  -------------   ------    ---------
<S>                                  <C>                 <C>         <C>             <C>       <C>
Soft Drink Replacer                   US 10/279,968      10/25/2002      US                     United
                                                                     2003/0134027               States

                                      PCT/NL02/00857     12/20/2002  WO 03/053 169               PCT

Preparation for the Prevention        PCT/NL02/00186     03/22/2002  WO 02/076241                PCT
and/or Treatment of Altered Bone
Metabolism
</TABLE><PAGE>

                                                                   EXHIBIT 10.9

                            PATENT LICENSE AGREEMENT

         This PATENT LICENSE AGREEMENT (this "Agreement"), dated December 5,
2003, (the "Effective Date") is made and entered into by and between General
Nutrition Corporation, an Arizona corporation (hereinafter the "Licensor"), and
N.V. Nutricia, a company organized under the laws of The Netherlands
(hereinafter the "Licensee").

         WHEREAS, Licensor is the owner of technology covered by certain Patent
Rights (as hereinafter defined) as a result of an Assignment, as of the date
hereof, of such Patent Rights from Licensee to Licensor (the "Assignment").

         WHEREAS, as a condition to said Assignment, Licensor agreed to grant an
exclusive right and license to Licensee for unrestricted exploitation of the
Patent Rights outside the Protected Business (as defined in that certain
Purchase Agreement, dated as of October 16, 2003, among Royal Numico N.V.,
Numico USA, Inc. and Apollo GNC Holding, Inc., as amended (the "Purchase
Agreement")) in order to continue to develop, manufacture, have manufactured,
market, offer for sale and sell certain product compositions and to sublicense
existing third party licensees.

         WHEREAS, this Agreement is made pursuant to and is subject to the terms
and conditions of the Purchase Agreement.

         NOW, THEREFORE, for good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereto, intending to be
legally bound, hereby agree as follows:

1.       DEFINITIONS

         1.1      As used in this Agreement, the capitalized terms set forth
herein shall have the following meanings:

                  (a)      "LICENSED PRODUCTS" means (i) any product composition
         outside the Protected Business, which if made, used or sold by
         Licensee, in the absence of the rights and license granted under this
         Agreement, would infringe one or more claims of the Patent Rights, or
         (ii) any method, process, procedure or technique within or outside the
         Protected Business, which if used or provided by Licensee, in the
         absence of the rights and license granted under this Agreement, would
         infringe one or more claims of the Patent Rights.

                  (b)      "PATENT RIGHTS" means (i) the patents (the "Patents")
         and the patent applications (the "Patent Applications") set forth in
         Exhibit A, attached hereto and incorporated herein, and (ii) any
         counterpart patents or patent applications that are equivalents of the
         Patents or Patent Applications issued, granted or filed in any country
         other than the

<PAGE>

         original filing country (the "Counterpart Patents"), including without
         limitation any continuation, continuation-in-part, divisional,
         reexamination, reissue or any other such patent right of the Patents or
         Patent Applications not expressly set forth herein as of the Effective
         Date; but exclusive of any continuation, continuation-in-part,
         divisional, reexamination, reissue or any other such patent right of
         the Patents or Patent Applications that are filed in Licensor's sole
         discretion after the Effective Date.

         1.2      "TERM" means the term of this Agreement as further defined in
Article 7 below.

         1.3      Capitalized terms used but not defined herein shall have the
meanings assigned thereto in the Purchase Agreement.

2.       LICENSE GRANT

         2.1      Licensor hereby grants to Licensee, subject to the terms and
conditions of this Agreement, an exclusive, worldwide, royalty-free right and
license, without the right to sublicense (except to Affiliates of Licensee and
as provided in Section 2.2), under the Patent Rights to make, have made, use,
offer for sale and sell Licensed Products outside the Protected Business.

         2.2      Prior to the Assignment, Licensee granted to certain third
parties the right and license to practice certain of the Patent Rights. Licensee
shall have the right and license to continue to sublicense such third parties in
accordance with the terms of any prior agreement between Licensee and such third
party.

         2.3      Licensor shall restrict its practice of the Patent Rights to
the Protected Business only, and covenants not to practice the Patent Rights for
any purpose outside the Protected Business.

3.       MARKING

         3.1      Licensee agrees to lawfully mark all Licensed Products (or
their containers or labels) with a proper patent marking based on the Patent
Rights pursuant to the U.S. Code Title 35 or any other international marking
requirements.

4.       PROSECUTION AND MAINTENANCE

         4.1      Licensor may, as it determines in its sole discretion: (a)
prosecute any and all U.S. and foreign patent applications included in or
related to the Patent Rights (the "Prosecution"); and (b) pay maintenance or
annuity fees of any and all U.S. and foreign patents which result from the
Patent Rights (the

                                       2

<PAGE>

"Maintenance"). Upon Licensee's written request, Licensor will furnish copies of
specifically requested Patent Rights-related documents to Licensee.

         4.2      In the event Licensor decides not to pursue Prosecution or
Maintenance of any of the Patent Rights, Licensor shall provide reasonable
notice to Licensee thereof. If Licensee desires, at its sole cost, expense and
discretion, to assume and continue the obligations of Prosecution or Maintenance
of such Patent Rights to Licensee, upon request by Licensee, Licensor shall
execute and deliver such documents and perform such acts as may be reasonably
necessary to effect assignment of all right, title and interest in and to such
Patent Rights, subject to any outstanding rights or licenses granted prior to
such assignment, without further consideration from Licensee.

         4.3      In the event that letters patent are issued or granted based
on any patent application so assigned in accordance with Section 4.2, Licensee
shall restrict its practice of such letters patent to making, having made,
using, offering for sale and selling products covered by the claims of such
letters patent outside the Protected Business and hereby grants to Licensor an
exclusive, royalty-free right and license, with the right to sublicense, under
such letters patent to make, have made, use, offer for sale and sell any
products covered by the claims of such letters patent within the Protected
Business and, except where the context otherwise requires, on such other terms
as the Patent Rights provided in this Agreement as if such Patent Rights
included such letters patent, Licensor as the Licensee hereunder with respect to
such letters patent and Licensee as the Licensor hereunder with respect to such
letters patent.

5.       INFRINGEMENT BY THIRD PARTIES

         5.1      Each party shall promptly give notice to the other of any
actual or potential infringement of any Patent Right by any third party that
becomes known to such first-mentioned party. Licensor shall have the first right
to take such action it determines, in its sole discretion, to be necessary to
terminate or prevent any actual or potential infringement of such Patent Right.
If Licensor has not taken any action (including an informed decision to take no
action) within one hundred twenty (120) days from such first-mentioned party's
notice, Licensee may submit to Licensor a notice that Licensee will take such
action as Licensee reasonably determines is necessary to terminate or prevent
the infringement, including filing suit to the extent provided by any applicable
law, rule or regulation, unless Licensor notifies Licensee that Licensor will
file suit or otherwise terminate such infringement within thirty (30) days after
Licensor's receipt of such notice from Licensee.

         5.2      In the event Licensor files suit to stop infringement.
Licensor may enter into any settlement, consent judgment or other voluntary
final disposition of such suit at its sole discretion. In the event Licensee
elects to

                                       3

<PAGE>

join Licensor in any such suit or action, Licensee shall pay it's own attorneys'
fees and costs of its participation in such suit or action. Regardless if
Licensee joins or does not join Licensor in any such suit or action, upon
request by Licensor, Licensee shall cooperate with Licensor in such suit or
action. In the event Licensor requests Licensee to join Licensor in
participation in such suit or action, Licensee shall have the right to consult
with Licensor and be represented by counsel at Licensor's sole expense. Any
recovery of damages from any suit or action brought by Licensor, where Licensee
has joined Licensor, shall be shared equally by the parties.

         5.3      In the event Licensee solely files suit to stop infringement,
Licensee may enter into any settlement, consent judgment or other voluntary
final disposition of such suit at its sole discretion, so long as the same does
not adversely affect Licensor's rights or interest in the Patent Rights. Any
recovery of damages from any suit or action brought solely by Licensee shall be
retained by Licensee.

6.       COSTS; EXPENSES AND TAXES

         6.1      Except as otherwise provided herein, each party shall bear its
own costs and expenses incurred by it in performing its obligations hereunder.

         6.2      Each party shall be responsible for payment of any applicable
sales, use and income taxes, including any privilege or excise taxes in the
nature of sales or use taxes, and other similar charges imposed upon it by any
jurisdiction arising from the performance of its obligations under this
Agreement.

7.       TERM AND TERMINATION

         7.1      The Term of this Agreement shall run from the Effective Date
of this Agreement and shall terminate automatically upon the expiration or
extinguishment of all of the Patent Rights set forth in Exhibit A and all
letters patent that may be issued as contemplated by Section 4.3, subject to
early termination, as set forth herein below:

                  (a)      Either party shall have the right to terminate this
         Agreement without judicial resolution upon written notice to the other
         party of a material breach of any provision of this Agreement by such
         other party that is not cured within sixty (60) days after such notice.

                  (b)      This Agreement shall be terminated immediately upon
         Licensor and Licensee reaching mutual agreement to so terminate this
         Agreement.

                  (c)      Licensee may terminate this Agreement without cause
         upon sixty (60) days notice to Licensor.

                                       4

<PAGE>

                  (d)      This Agreement shall automatically terminate, without
         requirement of notice, upon the occurrence of any of the following:

                           (i)      any attempt by Licensee to assign or
                  otherwise transfer its interest in whole or in part, in this
                  Agreement voluntarily or by operation of law to any other
                  third party except as otherwise permitted herein; or

                           (ii)     a cessation by Licensee of all or
                  substantially all of its business, or

                           (iii)    a petition in bankruptcy or reorganization
                  is filed by Licensee under any applicable bankruptcy law now
                  or hereafter in force or shall be filed against Licensee and
                  not vacated or dismissed within sixty (60) days after such
                  filing; or Licensee shall make an assignment for the benefit
                  of its creditors, or a receiver, trustee, liquidator or
                  custodian shall be appointed for all or a substantial part of
                  Licensee's property, and the order of appointment is not
                  vacated or dismissed within sixty (60) days after it is made;
                  or all or any material portion of Licensee's property shall be
                  sequestered, and the order of sequestration is not vacated or
                  dismissed within sixty (60) days after it is entered; or
                  Licensee shall generally fail or admit in writing its
                  inability to pay its debts as such debts become due and
                  payable.

         7.2      The following provisions of this Agreement shall survive
termination: Sections 7.3, 7.4 and 7.5, and Articles 6, 8, 9 and 10.

         7.3      Neither party shall be relieved of any obligation or liability
under this Agreement arising from any act or omission committed prior to the
effective date of such termination.

         7.4      Upon termination of this Agreement for any reason, and for one
(1) year following the effective date of termination, Licensee may continue to
sell any inventory of Licensed Products in its possession or control which was
manufactured, for which Licensee had issued binding commitments to manufacture
or for which Licensee had purchased or ordered raw materials to manufacture (all
in the ordinary course of business) prior to the effective date of termination.

         7.5      Except as specified in Section 7.4, from and after any
termination of this Agreement, Licensee shall not make or have made, use or have
used or sell or have sold any Licensed Products under any of the Patent Rights.

         7.6      The rights and remedies granted herein, and any other rights
or remedies which the parties may have, either at law or in equity, are
cumulative and not exclusive of others.

                                       5

<PAGE>

8.       LIMITATIONS OF WARRANTIES

         8.1      PATENT RIGHTS ARE PROVIDED "AS IS" WITH NO WARRANTIES OR
REPRESENTATIONS OF ANY KIND, AND LICENSOR EXPRESSLY DISCLAIMS ALL OTHER
WARRANTIES OR REPRESENTATIONS, EXPRESS OR IMPLIED, INCLUDING, BUT NOT LIMITED
TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, NON-INFRINGEMENT OR FITNESS FOR A
PARTICULAR PURPOSE.

9.       INDEMNIFICATION

         9.1      Licensee shall indemnify Licensor and its Affiliates against
all damages, costs, and expenses, including reasonable attorney's fees, arising
or resulting from, Licensee making, having made, using, offering for sale or
selling the Licensed Products based upon the Patent Rights in whatever form.

10.      LIMITATION OF LIABILITY

         10.1     Neither Licensor nor its Affiliates will be responsible for
any injury to or death of persons, or damage to or destruction of materials, or
other property, or for any other loss, damage, or injury of any kind whatsoever
resulting from Licensee making, having made, using, offering for sale or selling
of the Licensed Products based upon the Patent Rights.

11.      GENERAL PROVISIONS

         11.1     Under the terms of this Agreement, Licensor and Licensee are
independent contractors. Neither party is an employee, agent, partner or
representative of the other party. Nothing contained herein shall be deemed to
create a joint venture relationship between the parties. Each party specifically
acknowledges that it does not have authority to incur any obligations or
responsibilities on behalf of the other party.

         11.2     All notices required or permitted to be given by one party to
the other under this Agreement shall be sufficient if sent by certified mail,
return receipt requested, by a nationally recognized courier or by hand delivery
to the parties at the respective addresses set forth below or to such other
address as the party to receive the notice has designated by notice to the other
party:

Licensor:                                     Licensee:
General Nutrition Corporation                 N.V. Nutricia
300 Sixth Street                              Bosrandweg 20
Pittsburgh, Pennsylvania 15222                6704 PH Wageningen
Fax No._______________________                Netherlands
Attn:  _______________________                Fax No._________________________
                                              Attn:___________________________

                                       6

<PAGE>

         All notices shall be effective upon receipt or refusal of delivery by
the party being notified. Either party may change its address, etc., by giving
notice of such change as provided herein, provided that such notice is effective
only on receipt.

         11.3     Licensee shall not use the name of the Licensor or any of its
Affiliates in any advertising, marketing or sales without the prior written
consent of Licensor, except that Licensee may state that the Licensed Products
are licensed under the Patent Rights, Licensee may mark the Licensed Products
pursuant to Section 3 of this Agreement and Licensee may use Licensor's name in
various documents used by Licensee for capital raising and financing without
such prior written consent only to the extent such use is required by any U.S.
federal law or regulation. However, by entering into this Agreement, Licensor
does not directly or indirectly endorse any Licensed Products and Licensee shall
not state or imply that this Agreement is an endorsement by Licensor.

         11.4     NO waiver of the terms and conditions of this Agreement, or
the failure of either party to strictly enforce any such term or condition on
one or more occasions, shall be construed as a waiver of the same or of any
other term or condition of this Agreement on any other occasion.

         11.5     This Agreement shall be governed by and construed in
accordance with the internal laws of the State of New York, without reference to
any principles of conflicts of laws. The parties hereby consent to the
jurisdiction and venue of the United States district courts sitting in the State
of New York and any courts of the State of New York in which any suit, action or
proceeding is brought arising under this Agreement. The parties hereby waive any
claim of forum non conveniens in any suit, action or proceeding brought in any
of the above-mentioned courts. Licensor and Licensee agree that service of
process in any such suit, action or proceeding shall be effective if in writing,
delivered in any manner permitted in Section 11.2 hereof and actually received
by the addressee.

         11.6     If any provision in this Agreement may be held to be invalid
or unenforceable in any jurisdiction in which this Agreement is being performed,
the meaning of such provision shall be construed so as to render it enforceable
to the extent feasible. If no feasible interpretation would save such provision,
it shall be severed from this Agreement and the remainder shall remain in full
force and effect. However, in the event such provision is considered an
essential element of this Agreement, the parties shall promptly negotiate
alternative, reasonably equivalent, enforceable terms.

         11.7     Licensee shall comply with all laws, rules and regulations
applicable to the performance of its obligations hereunder, including, without

                                       7

<PAGE>

limitation, all import/export laws, restrictions, controls and regulations
relating to the Patent Rights and/or Licensed Products.

         11.8     Subject to the Purchase Agreement, the terms and conditions
contained in this Agreement, including the attached Exhibit A, supersede all
prior oral or written understandings between the parties with respect to the
subject matter thereof, and constitutes the entire agreement of the parties with
respect to such subject matter. All prior negotiations, representations,
agreements, and understandings are merged into, extinguished by and completely
expressed by this Agreement. Such terms and conditions shall not be modified or
amended except by a writing signed by authorized representatives of both
parties.

         11.9     This Agreement may be executed in several counterparts, each
of which shall be deemed an original, but all of which together shall constitute
one and the same Agreement. A signature page of this Agreement executed and
transmitted via facsimile or electronic mail shall be deemed an original for all
purposes.

         11.10    This Agreement shall be binding upon and shall inure to the
benefit of the parties hereto and their respective permitted assigns and
successors.

                            [SIGNATURE PAGE FOLLOWS]

                                        8

<PAGE>

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed below
by their duly authorized representatives.

General Nutrition Corporation              N.V. Nutricia

By: /s/ James Sander                       By: /s/ Bert Moulet
    -----------------------------              -------------------------------

Printed Name: James Sander                 Printed Name: Bert Moulet

Title: VP                                  Title: EVP
<PAGE>

                                    EXHIBIT A

<TABLE>
<CAPTION>
                                                    DATE                            DATE         COUNTRY
     PATENT TITLE               APPLN. NO.          FILED         PUBL. NO.        ISSUED         ISSUED
----------------------    ---------------------   ----------  ---------------   ------------    ---------
<S>                       <C>                     <C>         <C>               <C>             <C>
Composition                   US 09/812,839       03/21/2001  US 2002/0172732                    United
Comprising Cocoa                                                                                 States

                              AU 2002241397                                                     Australia

                          No application number                                                  Canada
                                  yet

                              EP 02707335.2                      EP 1370273                      Europe

Reducing Appetite in          US 09/956,463       09/20/2001      6,638,542       10/28/03       United
Mammals by                                                                                       States
Administering
Procyanidin and              WO 2002NL00607                     WO 03/024245                       PCT
Hydroxycitric Acid

Method for the                US 10/384,750       03/11/2003  US 2003/0175368                    United
Treatment and                                                                                    States
Prevention of
Overweight in
Mammals
                             PCT/NL03/00179       03/11/2003    WO 03/075941                      PCT

Method for the               PCT/NL03/00198       03/18/2003                                      PCT
Reduction of
Mammalian Appetite

Method for the                US 10/323,826       12/20/2002                                     United
Prevention or                                                                                    States
Treatment of
Overweight in
Mammals

Stimulation of In Vivo        US 10/325,711       12/20/2002                                     United
Production of                                                                                    States
Proteins

Method of Increasing          US 09/639,469       08/16/2000    US 6,495,170     12/17/2002      United
the Presence of                                                                                  States
Glutathione in Cells
                              DE 20011051148                    DE 10151148                      Germany

                               WO2001EP10671                    WO 03/024487                      PCT

                               US 10/284,158      10/31/2002  US 2003/0054048                    United
                                                                                                 States
</TABLE>

<PAGE>

<TABLE>
<S>                       <C>                      <C>          <C>               <C>         <C>
Compositions                  PCT/NL01/00233       03/22/2001     WO 01/70248                    PCT
Suitable for
the Treatment of Damage      AU 20010042876D                      AU 4287601                  Australia
Caused by Ischemia/
Reperfusion or               EP 20000201051                       EP 1136073                    Europe
Oxidative Stress
                             EP20010915929                        EP 1267901                   Europe

                             JP 20010568445T                     JP 2003527434                   Japan

Chlorogenic Acid and         US 09/734,389         08/15/2002    US 6,632,459     10/14/2003    United
an Analog Thereof for                                                                           States
Immune System
Stimulation
                            US Divisional - No                                                  United
                          application number yet                                                States

                            AU 20020025512D                       AU 2551202                   Australia

Method for the                US 10/015,582        12/17/2001   US 2003/0113310                 United
Treatment of Obesity,                                                                           States
Overweight and
Fluctuations in Blood         PCT/NL02/00836                      WO 03/051391                    PCT
Insuline and/ or
Glucose Levels
</TABLE>

                                       2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00065-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00065-of-00352.parquet"}]]